BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25244056)

  • 21. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
    Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
    BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of increased twist with lymph node metastasis in patients with oral squamous cell carcinoma.
    Wushou A; Pan HY; Liu W; Tian Z; Wang LZ; Shali S; Zhang ZY
    J Oral Maxillofac Surg; 2012 Jun; 70(6):1473-9. PubMed ID: 21864967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.
    Arora A; Husain N; Bansal A; Neyaz A; Jaiswal R; Jain K; Chaturvedi A; Anand N; Malhotra K; Shukla S
    Am J Surg Pathol; 2017 Jul; 41(7):950-960. PubMed ID: 28346327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
    Routray S; Kheur S; Chougule HM; Mohanty N; Dash R
    Ann Diagn Pathol; 2017 Oct; 30():36-41. PubMed ID: 28965626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.
    Velmurugan BK; Yeh KT; Lee CH; Lin SH; Chin MC; Chiang SL; Wang ZH; Hua CH; Tsai MH; Chang JG; Ko YC
    Oncotarget; 2016 Mar; 7(10):10879-90. PubMed ID: 26918356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical evaluation of MMP-2, MMP-9 and CD31/microvascular density in squamous cell carcinomas of the floor of the mouth.
    Monteiro-Amado F; Castro-Silva II; Lima CJ; Soares FA; Kowalski LP; Granjeiro JM
    Braz Dent J; 2013; 24(1):3-9. PubMed ID: 23657405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of lymphangiogenesis in supraglottic laryngeal carcinoma.
    Lin JY; Li XY; Dong P; Nakashima T
    J Laryngol Otol; 2011 Sep; 125(9):945-51. PubMed ID: 21774849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
    Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
    Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of lymph node ratio for patients with mandibular infiltration of oral squamous cell carcinoma.
    Safi AF; Kauke M; Grandoch A; Nickenig HJ; Zöller J; Kreppel M
    J Craniomaxillofac Surg; 2018 Jun; 46(6):1007-1012. PubMed ID: 29709331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral squamous cell carcinoma grading systems--analysis of the best survival predictor.
    Lindenblatt Rde C; Martinez GL; Silva LE; Faria PS; Camisasca DR; Lourenço Sde Q
    J Oral Pathol Med; 2012 Jan; 41(1):34-9. PubMed ID: 21902722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma.
    Kelner N; Rodrigues PC; Bufalino A; Fonseca FP; Santos-Silva AR; Miguel MC; Pinto CA; Leme AF; Graner E; Salo T; Kowalski LP; Coletta RD
    Head Neck; 2015 Apr; 37(4):479-86. PubMed ID: 24677273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
    Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
    Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
    Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
    Mehta A; Chowdhary M; Sinha R
    J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
    da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
    Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of differential β-catenin expression with Oct-4 and Nanog in oral squamous cell carcinoma and their correlation with clinicopathological factors and prognosis.
    Ravindran G; Sawant SS; Hague A; Kingsley K; Devaraj H
    Head Neck; 2015 Jul; 37(7):982-93. PubMed ID: 24700702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase-2--An Imperative Prognostic Biomarker in Oral Squamous Cell Carcinoma--An Immunohistochemical Study.
    Byatnal AA; Byatnal A; Sen S; Guddattu V; Solomon MC
    Pathol Oncol Res; 2015 Sep; 21(4):1123-31. PubMed ID: 25962348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas.
    González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
    J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.